Rockwell Medical (RMTI) Retained Earnings (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Retained Earnings came in at $440.3 million in Q1 2026, up 210.3% YoY from $141.9 million in Q1 2025, and up 209.26% on a QoQ basis from -$403.0 million in Q4 2025.
Rockwell Medical (RMTI) Retained Earnings (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Retained Earnings data on file, last reported at $440.3 million in Q1 2026.
- Quarterly Retained Earnings rose 210.3% year-over-year to $440.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $440.3 million (up 210.3% YoY) and the FY2025 annual result came in at -$403.0 million, down 193.67% from the prior year.
- Retained Earnings climbed to $440.3 million in Q1 2026, from -$403.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $440.3 million in Q1 2026 to a low of -$403.0 million in Q4 2025.
- A 5-year average of -$35.7 million and a median of -$5000.0 in 2024 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 210.7% in 2025, down 8013600.0% in 2025.
- Tracing RMTI's Retained Earnings over 5 years: stood at $402.7 million in 2022, then grew by 3.92% to $418.5 million in 2023, then increased by 2.8% to $430.2 million in 2024, then sank by 193.67% to -$403.0 million in 2025, then soared by 209.26% to $440.3 million in 2026.
- The last three Retained Earnings figures came in at $440.3 million (Q1 2026), -$403.0 million (Q4 2025), and $439.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Rockwell Medical | 31.73 Mn | 6.93 Mn | 3.24 Mn | 440.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 440.72 Mn |
| Mar 31, 2026 | 440.32 Mn |
| Dec 31, 2025 | -402.99 Mn |
| Sep 30, 2025 | 439.38 Mn |
| Jun 30, 2025 | -400.69 Mn |
| Mar 31, 2025 | -399.19 Mn |
| Dec 31, 2024 | 430.21 Mn |
| Sep 30, 2024 | -396.92 Mn |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 418.49 Mn |
| Sep 30, 2023 | -395.69 Mn |
| Jun 30, 2023 | 137,000.00 |
| Mar 31, 2023 | 402.89 Mn |
| Dec 31, 2022 | 402.70 Mn |
| Sep 30, 2022 | -386.40 Mn |
| Jun 30, 2022 | -382.21 Mn |
| Mar 31, 2022 | -377.24 Mn |
| Dec 31, 2021 | -370.08 Mn |
| Sep 30, 2021 | -361.10 Mn |